| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Avalo Therapeutics, Inc. (AVTX) has 9 insiders with recent SEC Form 4 filings, including 70 buys and 0 sells. AVTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 275.0K | $4.34M | - | |
| Other | 47.8K | $753.6K | -679 | |
| CFO | 19.1K | $301.4K | - | |
| Other | 3.6K | $57.3K | - | |
| Dir | 3.2K | $49.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 23, 2018 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 20,000 | $3.76 | $75,145.91 | - | |
| Apr 18, 2018 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 150,000 | $3.42 | $512,373.04 | +0.1% | |
| Dec 4, 2017 | Moscato Robert Jr. | COO | Buy | 285 | $1.77 | $504.45 | - | |
| Nov 24, 2017 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 45,200 | $1.20 | $54,190.28 | - | |
| Oct 16, 2017 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 4,800 | $1.08 | $5,174.40 | - | |
| Sep 29, 2017 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 6,883 | $0.87 | $5,986.15 | - | |
| Sep 28, 2017 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 13,952 | $0.80 | $11,105.24 | - | |
| Sep 22, 2017 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 14,660 | $0.78 | $11,494.05 | - | |
| Sep 20, 2017 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 51,369 | $0.75 | $38,705.66 | - | |
| Sep 8, 2017 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 4,299 | $0.74 | $3,198.84 | - |